Universal Medical buys vascular firms

Article

Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire

Universal Medical Systems of Clearwater, FL, has acquired threefirms that manufacture Pulse Volume Recorder, a device used todiagnose lower extremity arterial disease. UMSI purchased LifeSciences and two related companies, Biometrix New Hampshire andBiometrix Connecticut, for cash and about $650,000 in preferredstock.

Biometrix is developing Telepulse, a next-generation vasculardiagnostic system that includes a telemedicine capability by allowingattending physicians to transmit data for interpretation by aradiologist or vascular surgeon. The product has been clearedby the Food and Drug Administration and should be introduced inthe second half of 1996.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.